Market Research Report

Global Microbiome Therapeutics Market Report By Type (FMT, Microbiome Drugs), Application (C. Difficile, Crohn’s Disease, Inflammatory Bowel Disease, Diabetes, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

ID:VMR11210021
February 2022
Report Formats: Electronic (PDF), MS EXCEL

Microbiomes refers to the microorganisms residing in a particular environment, community or ecosystem. Basically, these microorganisms flourish in the areas like saliva, gastrointestinal tract (GT), etc. These microorganisms include bacteria, archaebacterial and fungi among many more. Microbiome Therapeutics refers to the development and advancement of therapies which interact with the gut microbiomes to improve the status of human health. The increasing number of population affected by inflammatory bowel diseases is the prime factor driving the microbiome therapeutics market.

As per Value Market Research, the Global Microbiome Therapeutics Market is expected to be worth USD 1477.68 Million by 2028 with a CAGR of 45.7%.
 
FMT EMERGE AS THE LEADING TYPE SEGMENT
Fecal Microbiota Transplant (FMT) is widely used in microbiome therapeutics. FMT market is rapidly growing owing to its properties such as cost-effective, having low risk and highly effective treatment. The market for FMT has estimated to touch USD XX.X Million revenue by the end of 2028.
 
C. DIFFICILE EMERGES AS THE LARGEST APPLICATION OF MICROBIOME THERAPEUTICS
As per the study of Centers for Disease Control and Prevention (CDC), half of a million people are affected by C. difficile infection in the United States is majorly driving the segment growth. Further, the increasing number of death (approximately 29000 in the 30 days of initial diagnosis) caused life-threatening infection is again fueling the growth. It is estimated to reach USD XX.X Million revenue by the end of 2028.
 
NORTH AMERICA MARKET IS GAINING THE MOMENTUM
North America is accounted for the remarkable growth in the microbiome therapeutics market owing to the growing number of aging population. Additionally, the well-established research facilities along with the availability of advanced novel therapeutics are again fueling the regional growth. Further, the presence of key players helps North America to dominate the market. As a result, North America is expected to reach USD XX.X Million by the end of 2018.
 
PROMINENT PLAYERS IN THE GLOBAL MARKET
Enterome Bioscience, MaaT Pharma, MicroBiome Therapeutics LLC, OpenBiome, Rebiotix, Inc., Ritter Pharmaceuticals Inc., Second Genome, and Seres Therapeutics Inc. are the major players driving in the global microbiome therapeutics market.

As per this study, the Global Microbiome Therapeutics Market is anticipated to reach USD 1477.68 Million by 2028 with a CAGR of 45.7%.
 
Microbiomes refers to the microorganisms residing in a particular environment, community or ecosystem. Microorganisms living in a particular ecosystem are also referred to as microbiota. Generally, these microorganisms flourish in the areas like saliva, gastrointestinal tract (GT), etc. These microorganisms include bacteria, archaebacteria, and fungi among many more. The health state of a person is highly dependent on such beneficial microbiomes. A healthy person houses a vast diversity of colonies of bacteria living together contributing to a healthier living of the person, and weigh about 3 pounds in an average adult. However, the lack of such diversity attracts numerous diseases.
 
Market Dynamics
 
Increasing demand for treatments with high efficiency along with the increase in a number of inflammatory bowel disease and diabetes is expected to drive the market demand. Technological advancements, high acceptance, and increasing awareness are further supporting the market growth. However, high cost due to complexities in the development process and a limited set of regulations may hamper the market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of microbiome therapeutics.
 
Market Segmentation
 
The broad microbiome therapeutics market has been sub-grouped into type and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Type
  • FMT
  • Microbiome Drugs
 
By Application
  • C. Difficile
  • Crohn’s Disease
  • Inflammatory Bowel Disease
  • Diabetes
  • Others
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for microbiome therapeutics in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Global Microbiome Therapeutics Market Share by Region (Representative Graph)
 
Global Microbiome Therapeutics Market Share
 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the microbiome therapeutics market includes Enterome Bioscience, MaaT Pharma, MicroBiome Therapeutics LLC, OpenBiome, Rebiotix, Inc., Ritter Pharmaceuticals Inc., Second Genome, and Seres Therapeutics Inc. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . MICROBIOME THERAPEUTICS – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 Market Attractiveness Analysis By Type
           3.7.2 Market Attractiveness Analysis By Application
           3.7.3 Market Attractiveness Analysis By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic 
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL MICROBIOME THERAPEUTICS MARKET ANALYSIS BY TYPE
       6.1 Overview by Type
       6.2 Historical and Forecast Data
       6.3 Analysis by Type
       6.4 FMT Historic and Forecast Sales by Regions
       6.5 Microbiome Drugs Historic and Forecast Sales by Regions
 
7 . GLOBAL MICROBIOME THERAPEUTICS MARKET ANALYSIS BY APPLICATION
       7.1 Overview by Application
       7.2 Historical and Forecast Data
       7.3 Analysis by Application
       7.4 C. Difficile Historic and Forecast Sales by Regions
       7.5 Crohn’s Disease Historic and Forecast Sales by Regions
       7.6 Inflammatory Bowel Disease Historic and Forecast Sales by Regions
       7.7 Diabetes Historic and Forecast Sales by Regions
       7.8 Others Historic and Forecast Sales by Regions
 
8 . GLOBAL MICROBIOME THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America Sales Analysis
           8.3.1. Overview, Historic and Forecast Sales Analysis
           8.3.2. North America By Segment Sales Analysis
           8.3.3. North America By Country Sales Analysis
           8.3.4. United State Sales Analysis
           8.3.5. Canada Sales Analysis
           8.3.6. Mexico Sales Analysis
       8.4. Europe Sales Analysis
           8.4.1. Overview, Historic and Forecast Sales Analysis
           8.4.2. Europe by Segment Sales Analysis
           8.4.3. Europe by Country Sales Analysis
           8.4.4. United Kingdom Sales Analysis
           8.4.5. France Sales Analysis
           8.4.6. Germany Sales Analysis
           8.4.7. Italy Sales Analysis
           8.4.8. Russia Sales Analysis
           8.4.9. Rest Of Europe Sales Analysis
       8.5. Asia Pacific Sales Analysis
           8.5.1. Overview, Historic and Forecast Sales Analysis
           8.5.2. Asia Pacific by Segment Sales Analysis
           8.5.3. Asia Pacific by Country Sales Analysis
           8.5.4. China Sales Analysis
           8.5.5. India Sales Analysis
           8.5.6. Japan Sales Analysis
           8.5.7. South Korea Sales Analysis
           8.5.8. Australia Sales Analysis
           8.5.9. Rest Of Asia Pacific Sales Analysis
       8.6. Latin America Sales Analysis
           8.6.1. Overview, Historic and Forecast Sales Analysis
           8.6.2. Latin America by Segment Sales Analysis
           8.6.3. Latin America by Country Sales Analysis
           8.6.4. Brazil Sales Analysis
           8.6.5. Argentina Sales Analysis
           8.6.6. Peru Sales Analysis
           8.6.7. Chile Sales Analysis
           8.6.8. Rest of Latin America Sales Analysis
       8.7. Middle East & Africa Sales Analysis
           8.7.1. Overview, Historic and Forecast Sales Analysis
           8.7.2. Middle East & Africa by Segment Sales Analysis
           8.7.3. Middle East & Africa by Country Sales Analysis
           8.7.4. Saudi Arabia Sales Analysis
           8.7.5. UAE Sales Analysis
           8.7.6. Israel Sales Analysis
           8.7.7. South Africa Sales Analysis
           8.7.8. Rest Of Middle East And Africa Sales Analysis
 
9 . COMPETITIVE LANDSCAPE OF THE MICROBIOME THERAPEUTICS COMPANIES
       9.1. Microbiome Therapeutics Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF MICROBIOME THERAPEUTICS INDUSTRY
       10.1. Top 10  Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Enterome Bioscience
           10.3.1. Company Overview
           10.3.2. Company Revenue
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. MaaT Pharma
           10.4.1. Company Overview
           10.4.2. Company Revenue
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. MicroBiome Therapeutics LLC
           10.5.1. Company Overview
           10.5.2. Company Revenue
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. OpenBiome
           10.6.1. Company Overview
           10.6.2. Company Revenue
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Rebiotix Inc.
           10.7.1. Company Overview
           10.7.2. Company Revenue
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Ritter Pharmaceuticals Inc.
           10.8.1. Company Overview
           10.8.2. Company Revenue
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. Second Genome
           10.9.1. Company Overview
           10.9.2. Company Revenue
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Seres Therapeutics Inc
           10.10.1. Company Overview
           10.10.2. Company Revenue
           10.10.3. Products
           10.10.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES
 

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  •  COVID-19: Micro and Macro Factor Analysis
  •  Analysis by Type (USD MN)
  •  FMT Market Sales by Geography (USD MN)
  •  Microbiome Drugs Market Sales by Geography (USD MN)
  •  Analysis Market by Application (USD MN)
  •  C. Difficile Market Sales by Geography (USD MN)
  •  Crohn’s Disease Market Sales by Geography (USD MN)
  •  Inflammatory Bowel Disease Market Sales by Geography (USD MN)
  •  Diabetes Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Microbiome Therapeutics Market Sales by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisiton
 
 LIST OF FIGURES
 
  •  Research Scope of Microbiome Therapeutics Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Microbiome Therapeutics Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Type
  •  Market Attractiveness Analysis by Application
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Type (USD MN)
  •  FMT Market Sales by Geography (USD MN)
  •  Microbiome Drugs Market Sales by Geography (USD MN)
  •  Global Market Analysis by Application (USD MN)
  •  C. Difficile Market Sales by Geography (USD MN)
  •  Crohn’s Disease Market Sales by Geography (USD MN)
  •  Inflammatory Bowel Disease Market Sales by Geography (USD MN)
  •  Diabetes Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Top 10  Company Share Analysis
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
After Sales Support
24/7 Email Support

Clients

Testimonials